Found 39 matching trials
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
PHASE3To explore the safety and efficacy of NALIRIFOX plus targeted therapy versu...
Location
Shanghai Zhongshan Hospital
Neoadjuvant Therapy (NALIRIFOX) for Locally Advanced Colon and Upper Rectal Cancer
PHASE4The goal of this clinical trial is to evaluating the efficacy and safety of...
Status
Active Not Recruiting
Location
Cancer Hospital of Shantou University Medical College
Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
N/AThis is multicenter, prospective, open label, non-interventional study that...
Location
Attikon University General Hospital
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
PHASE2This study is a multicenter, open-label, phase II study to evaluate the saf...
Location
Peking Union Medical College Hospital
Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2A prospective, interventional, single-center, single-arm, open-label, phase...
Location
Imbert Cancer Center
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer
PHASE2This is a prospective, open-label, single arm clinical study. The main purp...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
PHASE2The study regimen will be administered on an outpatient basis and all medic...
Location
Moffitt Cancer Center
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
PHASE2The purpose of this study is to perform a pilot phase II trial to evaluate ...
Location
The University of Texas Health Science Center at Houston
Short-course RT Followed by NALIRIFOX Plus Pucotenlimab as Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer With MSS/pMMR
PHASE2The goal of this clinical trial is conducted to evaluate the neoadjuvant re...
Location
Multiple Locations
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
PHASE1This multicentric open-label trial will compare the efficacy and safety of ...
Location
Multiple Locations